Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on July 18, 2024, by Catheter Precision, Inc., a Delaware corporation. The filing discloses the entry into a material definitive agreement involving a short-term loan from an entity controlled by the company's Executive Chair and CEO, David A. Jenkins.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. The specific financial event reported is:
- New Debt: $100,000 principal amount.
- Interest Rate: 8% per annum.
- Maturity Date: August 30, 2024.
- Related Party Debt Context: This loan is in addition to $500,000 loaned by Mr. Jenkins in May 2024 and $400,000 loaned by an entity controlled by Mr. Jenkins in June and July 2024.
Material Changes and Related Party Transactions
The primary material change is the creation of a new direct financial obligation. The lender is an entity controlled by David A. Jenkins, who beneficially owns over 10% of the company's common stock and holds significant convertible preferred stock and royalty rights. The note includes standard acceleration clauses triggered by events of default, including failure to pay, material breach of representations, or insolvency proceedings.
Outlook, Risks, and Management Commentary
Repayment Source: Management expects the note to be repaid from proceeds received from the sale of securities pursuant to the company's registration statement on Form S-1 (Registration No. 333-279930).
Risks: The company faces liquidity risk if the anticipated capital raise does not occur before the August 30, 2024 maturity date, which could trigger an event of default and immediate acceleration of the debt.
Investor Verification Checklist
- Verify the status of the Form S-1 registration statement (No. 333-279930) and whether the capital raise has been completed or is imminent.
- Confirm the total outstanding debt owed to David A. Jenkins and his affiliates ($1.0 million cumulative as of this filing).
- Review the terms of the royalty agreements and convertible preferred stock held by Mr. Jenkins to understand potential dilution or cash flow impacts.
- Monitor for any subsequent filings regarding the repayment of this note or the extension of its maturity date.